09.04.24 -- NIST, IBBR Researchers Explore Excipient-Influenced mAb Dynamics At Atomic Level

Discover in our technical article the Downstream Purification in the Plasmid DNA (pDNA) Manufacturing Process. Plasmid DNA (pDNA) is an essential component of, and key technology for production of viral vector, mRNA, and vaccine therapies. The far-reaching potential of novel therapeutic modalities and vaccines that rely on pDNA is driving increased demand and the need for improved production strategies – Read Now!

Join us on September 18th as we address obstacles faced during the transition to continuous processing, such as integration, real-time monitoring, and regulatory compliance. Learn practical solutions and technological advancements that can mitigate these issues, ensuring a smooth and effective implementation. We will highlight how inline buffer formulation supports seamless continuous production and how to leverage this technology to optimize your biopharmaceutical manufacturing processes.

This webinar delves into the strategic use of peptones within vaccine bioprocessing to optimize vaccine yield and quality. We will examine how the implementation of peptones in Vero and HEK cell lines can significantly reduce serum usage and enhance productivity, leading to substantial cost savings. We’ll also address the challenge of peptone variability, offering insights into how to manage consistency in your bioprocessing workflow.